Capitolis Liquid Global Markets’s AbbVie ABBV Stock Holding History

Capitolis Liquid Global Markets’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$105M	Sell	417,193 -256,251	-38%	-$55.1M	0.46%	53
2026 Q1	$146M	Buy	673,444 +127	+0%	+$28.2K	0.93%	20
2025 Q4	$154M	Buy	673,317 +82,246	+14%	+$18.7M	0.92%	24
2025 Q3	$137M	Sell	591,071 -51,229	-8%	-$10.4M	1.09%	21
2025 Q2	$119M	Buy	642,300 +30,000	+5%	+$5.58M	0.87%	27
2025 Q1	$128M	Sell	612,300 -37,700	-6%	-$7.33M	1.13%	19
2024 Q4	$116M	Sell	650,000 -160,000	-20%	-$29.4M	1.13%	19
2024 Q3	$160M	Buy	810,000 +770,000	+1,925%	+$144M	1.7%	17
2024 Q2	$6.86M	Hold	40,000	–	–	0.08%	93
2024 Q1	$7.28M	Sell	40,000 -70,000	-64%	-$12.1M	0.12%	93
2023 Q4	$17M	Buy	+110,000	New	+$16M	0.7%	35

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capitolis Liquid Global Markets's ABBV Position: Q2 2026 in Review

Capitolis Liquid Global Markets reduced its AbbVie (ABBV) stake by 38% in Q2 2026, selling an estimated $55.1M and leaving 417,193 shares worth $105M. The position accounts for 0.46% of the portfolio, ranked #53.

Capitolis Liquid Global Markets first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $160M in Q3 2024. 4,214 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Capitolis Liquid Global Markets held 417,193 shares of AbbVie worth $105M as of Q2 2026.
Capitolis Liquid Global Markets sold 256,251 AbbVie shares in Q2 2026, an estimated $55.1M.
AbbVie made up 0.46% of Capitolis Liquid Global Markets's portfolio in Q2 2026, its #53 holding.
Capitolis Liquid Global Markets first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
Capitolis Liquid Global Markets's AbbVie position peaked at $160M in Q3 2024.
4,214 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Capitolis Liquid Global Markets's 13F filing for Q2 2026, filed 13 Aug 2026.